Table 24 (abstract P63). See text for description
From: Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one
Africa | Asia | Eastern Europe | Latin America | North America | Western Europe | |
|---|---|---|---|---|---|---|
N = 261 | N = 874 | N = 2587 | N = 814 | N = 422 | N = 3367 | |
Median (IQR) age at onset, years | 7 (3.6–10.5) | 5.7 (2.9–9.2) | 6.4 (2.9–10.5) | 6.6 (3.6–10.3) | 8.1 (3.7–11.1) | 4.1 (2–8.7) |
Systemic arthritis | 17.2 | 26.5 | 8.1 | 17.7 | 4.7 | 6.9 |
Oligoarthritis | 23 | 31.9 | 44.1 | 31.7 | 33.9 | 49.2 |
Uveitis | 4.6 | 5.5 | 10 | 6.6 | 10.4 | 16.9 |
Use of biologics | 22.6 | 23.6 | 28.9 | 34.2 | 47.6 | 39 |
Median (IQR) cJADAS10 | 7 (2–11) | 2.5 (0–7.8) | 4.5 (1–9.5) | 2.5 (0–9.5) | 2.3 (0–7) | 2 (0–6) |
Median (IQR) JAFS score | 4 (0–8) | 1 (0–5) | 1 (0–4) | 1 (0–5) | 1 (0–4) | 0 (0–3) |
JADI-Articular > 0 | 27.6 | 19.2 | 23.7 | 31.9 | 15.2 | 12.2 |
JADI-Extraarticular > 0 | 24.5 | 16.8 | 14.8 | 14.5 | 5.9 | 9.1 |